COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,199 Articles (22,713 medRxiv, 8,486 bioRxiv)

Most recent first Previous |  Page 2966: Articles 29651-29660  | Next

Association Between BCG Policy is Significantly Confounded by Age and is Unlikely to Alter Infection or Mortality Rates
Kirov, S.
10.1101/2020.04.06.20055616 — Posted: 2020-04-11
Analysing and comparing the COVID-19 data: The closed cases of Hubei and South Korea, the dark March in Europe, the beginning of the outbreak in South America
De Leo, S., Maia, G. G., Solidoro, L.
10.1101/2020.04.06.20055327 — Posted: 2020-04-11
Effectiveness of quarantine measure on transmission dynamics of COVID-19 in Hong Kong
Yuan, H.-Y., Mao, A., Han, G., Yuan, H., Pfeiffer, D.
10.1101/2020.04.09.20059006 — Posted: 2020-04-11
Population age structure only partially explains the large number of COVID-19 deaths at the oldest ages
Medfod, A., Trias-Llimos, S.
10.1101/2020.04.09.20056341 — Posted: 2020-04-11
To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic
Eikenberry, S. E., Mancuso, M., Iboi, E., Phan, T., Eikenberry, K., Kuang, Y., Kostelich, E., Gumel, A. B.
10.1101/2020.04.06.20055624 — Posted: 2020-04-11
High-throughput extraction of SARS-CoV-2 RNA from nasopharyngeal swabs using solid-phase reverse immobilization beads
Kalikiri, M. K. R., Hasan, M. R., Mirza, F., Xaba, T., Tang, P., Lorenz, S.
10.1101/2020.04.08.20055731 — Posted: 2020-04-11
Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
Ye, L., Chen, X., Li, R., Pan, Z., Qian, C., Yang, Y., You, R., Zhao, J., Gao, L., Li, Z., Huang, Q., Xu, L., Tang, J., Tian, Q., Yao, W., Hu, L., Yan, X., Zhou, X., Liu, P., Wu, Y., Deng, K., Zhang, Z., Chen, Y., Qian, Z.
10.1101/2020.04.06.20055475 — Posted: 2020-04-11 Discussion: Offsite
Multi-route respiratory infection: when a transmission route may dominate
Gao, C. X., Li, Y., Wei, J., Cotton, S., Hamilton, M., Wang, L., Cowling, B. J.
10.1101/2020.04.06.20055228 — Posted: 2020-04-11
Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study)
Borba, M., Val, F. d. A., Sampaio, V. S., Alexandre, M. A., Melo, G. C., Brito, M., Mourao, M., Brito Sousa, J. D., Baia-da-Silva, d., Guerra, M. V. F., Hajjar, L., Pinto, R. C., Balieiro, A., Naveca, F. G., Xavier, M., Salomao, A., Siqueira, A., Schwarzbolt, A., Croda, J. H. R., Nogueira, M. L., Romero, G., Bassat, Q., Fontes, C. J., Albuquerque, B., Daniel-Ribeiro, C., Monteiro, W., Lacerda, M., CloroCovid-19 Team
10.1101/2020.04.07.20056424 — Posted: 2020-04-11 Discussion: Onsite | Offsite
Development of a dual-gene loop-mediated isothermal amplification (LAMP) detection assay for SARS-CoV-2: A preliminary study
Butt, A. M., Siddique, S., An, X., Tong, Y.
10.1101/2020.04.08.20056986 — Posted: 2020-04-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).